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Abstract
Background: Systematic reviews have developed into a powerful method for summarising and
synthesising evidence. The rise in systematic reviews creates a methodological opportunity and
associated challenges and this is seen in the development of overviews, or reviews of systematic
reviews. One of these challenges i s how  to summari se  evide nce from systematic revie ws of
complex interventions for inclusion in an overview. Interventions for communicating with and
involving consumers in their care are frequently complex. In this article we outline a method for
preparing data integration tables to enable review-level synthesis of the evidence on interventions
for communication and participation in health.
Methods and Results: Systematic reviews published by the Cochrane Consumers and
Communication Review Group were utilised as the basis from which to develop linked steps for
data extraction, evidence assessment and synthesis. The resulting output is called a data integration
table. Four steps were undertaken in designing the data integration tables: first, relevant
information for a comprehensive picture of the characteristics of the review was identified from
each review, extracted and summarised. Second, results for the outcomes of the review were
assessed and translated to standardised evidence statements. Third, outcomes and evidence
statements were mapped into an outcome taxonomy that we developed, using language specific to
the field of interventions for communication and participation. Fourth, the implications of the
review were assessed after the mapping step clarified the level of evidence available for each
intervention.
Conclusion: The data integration tables represent building blocks for constructing overviews of
review-level evidence and for the conduct of meta-synthesis. Individually, each table aims to
improve the consistency of reporting on the features and effects of interventions for
communication and participation; provides a broad assessment of the strength of evidence derived
from different methods of analysis; indicates a degree of certainty with results; and reports
outcomes and gaps in the evidence in a consistent and coherent way. In addition, individual tables
can serve as a valuable tool for accurate dissemination of large amounts of complex information on
communication and participation to professionals as well as to members of the public.
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Background
Systematic reviews have developed into a powerful
method for summarising and synthesising evidence
derived from trials and other predominantly experimental
studies, and their use by decision makers in clinical and
policy settings is increasingly promoted and accepted [1].
The rise in the number of systematic reviews creates a new
methodological opportunity and associated challenges
and this is seen in the development of overviews, or
reviews of systematic reviews (Ch. 22 [2]). One of these
challenges is how to summarise evidence from systematic
reviews of complex interventions for inclusion in an over-
view. Complex interventions are so called because of the
dynamic, multifaceted, interacting and socially contin-
gent nature of the interventions and their application [3].
Interventions for communication and participation
The Cochrane Consumers and Communication Review
Group coordinates the production of Cochrane systematic
reviews of interventions which affect consumers' interac-
tions with healthcare professionals and the health system.
In describing the work of the review group, we use the
term 'consumers' to include patients, their family carers,
or members of the public with an interest in health. For
brevity, we describe the wide range of interventions which
affect people's interactions as interventions to communi-
cate with and promote the participation of consumers in
health care. Many of the interventions covered by the
scope of the review group would be classified as complex
according to the UK's Medical Research Council defini-
tion mentioned above [3]. A few examples illustrate both
the complexity and diversity: interventions to improve
consumers' adherence to medicines could include instruc-
tion, counselling or psychological therapy, simplified
dosing, self-monitoring, reminders, lay health mentoring,
crisis or family interventions, and many others, and these
can each be delivered alone or as complex multifaceted
interventions [4].
Broadly, interventions for improving communication and
increasing participation aim to promote consumers who:
￿ are more knowledgeable and competent;
￿ are able to express and exchange their views and beliefs,
￿ make treatment and healthy behaviour choices alone or
with health professionals;
￿ seek or provide support if required;
￿ minimise risks and harms;
￿ are able to access high quality information and quality
health services; and
￿ participate in policy making, planning, service improve-
ment and research.
These aims will therefore relate to the wide range of out-
comes being sought, and which might affect individuals
(consumers or professionals), health services and systems,
as well as contribute to societal goals, for example, health-
ier populations.
As indicated, interventions for communication and par-
ticipation are characterised by the diversity and multiplic-
ity of their purposes and the complexity of the situations
surrounding their use. They may operate at the level of
individuals, groups, systems, organisations or society,
they may be applied through many different media in
addition to human interaction, and their delivery may
involve many players. For example, contract-based inter-
ventions to improve adherence to treatment, screening or
health promotion may be directed at patients, family car-
ers and/or professionals providing these services [5].
Some interventions may be developed to be disease-spe-
cific, although many have general application across pop-
ulations (or could be adapted to be so). Consequently,
many reviews coordinated by the Consumers and Com-
munication Review Group are broad in focus, rather than
narrow, thus making them relevant and important for the
treatment and management of many diseases, and to the
formation of health policies for more responsive health
systems.
Overviews of the effects of interventions for 
communication and participation
The World Health Organization, through its Regional
Office for the Western Pacific, has developed a policy
framework for a more responsive and people-centred
health system [6] and during this process commissioned
the Consumers and Communication Review Group to
provide summaries of systematic reviews to inform the
development of the framework. At the time the project
commenced (2004), methodology for the preparation of
overviews or reviews of systematic reviews was at an ear-
lier stage. Our view in 2004 was that overviews could play
an important role in informing policy, health profession-
als and consumers about the state of evidence, enabling
summary and comparison across a wide range of interven-
tion types and settings. The issue we debated was whether
an overview should be a straightforward summary of the
results of included systematic reviews, that is, it would be
not much more than a listing of summaries of data largely
derived from the abstracts of reviews, or alternatively it
could provide more information and be in a format that
enabled a 'higher' or meta level of analysis.
Decisions on which data to collect and analyse are framed
by the question that is posed. In the case of a systematicBMC Medical Research Methodology 2009, 9:16 http://www.biomedcentral.com/1471-2288/9/16
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review, the question might be what are the effects of inter-
ventions to improve adherence to medicines [4], whereas
an overview might ask the broader question of what inter-
ventions directed to consumers improve the use of medi-
cines – including, for example, procurement, consumers'
understanding, and medical outcomes as well as adher-
ence [7]. However, in seeking to contribute to the devel-
opment of policy, and in recognition of some of the
challenges of summarising review-level evidence for com-
plex interventions, we opted to provide more than the
information that is currently provided in a typical abstract
of a review. This choice led us to develop a method that
would enable standardised messages on the evidence, its
uncertainties and evidence gaps, and which would be con-
cise but sufficiently informative for policy deliberation
[8].
The process of summarising systematic reviews of inter-
ventions for communication and participation was more
difficult than we anticipated and in the course of the work
for WHO and other bodies subsequently, we have devel-
oped a method of summarising and assessing data from
systematic reviews which is also an output. We call the
output 'data integration tables'. The term data integration
table was chosen because it indicates key inputs to this
process: data that are selected, a process of integrating
data, and data that are tabulated (either for stand-alone
purposes, such as dissemination of the review results, or
for inclusion in the next (higher) stage of analysis). The
output is therefore both a series of steps and a table: the
tables themselves can then be used (entire or modified) in
different ways. This article describes the developmental
process of the data integration tables. In relation to other
key terms, and in common with others [2], we call a
review of systematic reviews an overview and we term the
method of analysis in an overview meta-synthesis. This
article does not describe the analytical process of meta-
synthesis but it does consider the implications of the data
integration tables in the context of conducting a meta-syn-
thesis.
Developments in the science of synthesis and meta-
synthesis
As mentioned above, the production and use of system-
atic reviews has risen at pace with the increasing amount
of primary literature available. As the science of research
synthesis has developed interest has also grown in ways to
combine and present review-level evidence in accessible,
consistent formats [8-13].
Overviews have been used to respond to clinical questions
such as the effectiveness of a range of interventions for a
particular condition (Ch. 22 [2]); or the effects of the
same intervention across conditions. Cochrane Collabo-
ration review groups, including the Cochrane Muscu-
loskeletal, Cochrane Menstrual Disorders and Subfertility,
and the Cochrane HIV/AIDS Groups, have developed
methods and prepared overviews to address these types of
questions [14-16]. Others have focussed on addressing
the needs of policy makers in relation to evidence-based
decision making in health priority areas [17]. This work
has involved the development of rating schemes to stand-
ardise and report outcomes. Using these tools, the
strength of evidence derived from reviews can be rated
and summarised in relation to key outcomes.
Methodological approaches to preparing overviews vary
according to their aims (for instance, to be an input to
policy deliberation, to develop specific recommenda-
tions, or to inform the field about the effects of different
strategies) and key audiences (this may be dependent on
who would implement the interventions). They are also
determined by the populations, interventions and out-
comes evaluated in systematic reviews. For example, the
interventions assessed in clinically-focussed reviews are,
in general, less complex and diverse than those seen in
areas incorporating social complexity or social process,
such as communication and participation in health.
Reviews of clinical interventions also typically focus on a
relatively narrow range of outcomes that are readily meas-
urable in a clearly defined population. This contrasts with
the hugely diverse outcomes, assessed in a multitude of
ways, that typify systematic reviews of public health and
socially complex interventions [10,18,19]. In these latter
categories, a narrative report and synthesis of results
rather than statistical meta-analysis is more common, due
to the heterogeneity of the included studies. Such differ-
ences and others mean that meta-synthesis methods must
be developed to accommodate methodological complex-
ity but remain able to be tailored to assist the analytic
process. In other words, meta-synthesis must be more
than just a listing of findings from individual systematic
reviews.
We were unable to find a model of synthesising review-
level evidence with direct applicability to the area of com-
municating with and promoting the participation of con-
sumers in health. Models with a clinical or public health
focus provided a basis for approaching assessments and
rating of the strength of evidence. However, these
approaches did not provide a clear basis for standardising
the reporting of diverse outcomes spanning clinical or dis-
ease areas, one of the most difficult features of the evi-
dence on communication and participation. Our aim was
to develop a model of synthesis that might standardise the
evidence and so enable broad questions about the effec-
tiveness of interventions for communication and partici-
pation to be answered, such as what helps people to make
informed decisions about screening? We therefore sought
to develop methods that would deal with the particularBMC Medical Research Methodology 2009, 9:16 http://www.biomedcentral.com/1471-2288/9/16
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features of the evidence on communication and participa-
tion and provide us with a basis for the preparation of
overviews, or meta-synthesis.
This article describes the developmental process, method-
ological issues, in association with its output or result, so
for ease of understanding we have combined the tradi-
tional Methods and Results sections into one. The Discus-
sion section describes the uses of the tables, their strengths
and limitations, and future work.
Methods and results
Data integration tables: Development and production
Four steps were undertaken in designing the data integra-
tion tables: first, relevant information for tabulating key
characteristics of a review was identified, extracted and
summarised. Second, results for the outcomes of the
review were assessed and translated to standardised evi-
dence statements. Third, the outcomes and evidence state-
ments were mapped into an outcome taxonomy that we
developed, using language specific to the field of interven-
tions for communication and participation. Fourth, the
implications of the review were assessed after the map-
ping step clarified the level of evidence available for each
intervention.
For each of these Steps 1–4, we outline the methods we
adopted, methodological issues debated, modifications
required and the output or result of each step. Tables 1, 2,
3 illustrate key inputs: see Additional file 1 for a worked
example of a data integration table for one entire system-
atic review.
Step 1: Summarising key characteristics of reviews
The first step involved identifying information from a
review that would provide a context for interpreting it and
Table 1: Major characteristics extracted from reviews published by the Cochrane Consumers and Communication Review Group
Description of main review characteristics and the data extracted from reviews for each characteristic
Aim Adapted from review objectives.
Scope – Study design, Participants, Interventions, Comparison arms, 
Outcomes
Adapted from review selection criteria; the number and type of studies 
and participant numbers included were also extracted.
Number and types of studies
Number of participants
Analysis Indicates whether meta-analysis and/or narrative data analysis was 
performed.
Setting Country and predominant settings in which included studies were 
conducted and interventions delivered.
Recipient Adapted from the Consumers and Communication Review Group 
scope, which groups reviews via direction of the communication 
processes (e.g. to the consumer; from the consumer; between provider 
and consumer; between consumers), so describing both the primary 
intervention recipient and the major direction of communication 
processes.
Provider Who delivered the intervention to the recipient. Also describes 
important characteristics such as experience or training required to 
deliver the intervention.
Format The predominant delivery format(s) of the intervention. May also 
include important characteristics such as frequency, intensity or delivery 
to individuals or groups.
Quality Quality of included studies: summary based on review authors' criteria 
used to rate included study quality and authors' assessment of included 
study quality.
Quality of the review: based on AMSTAR; includes the overall quality 
score and summary of criteria that review methods failed to meet.
Authors' conclusions Authors' conclusions added as a composite of points raised in the 
Discussion and Implications (for practice, for research) sections of the 
Cochrane review.BMC Medical Research Methodology 2009, 9:16 http://www.biomedcentral.com/1471-2288/9/16
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aid an assessment of applicability by policy makers. This
step also included two quality assessments – of the review,
and of its included trials. Combined, this information
summarised the key characteristics of the systematic
review.
Identifying and extracting data
We looked systematically across all published Cochrane
reviews whose preparation was coordinated by the Con-
sumers and Communication Review Group to identify
key categories of information needed to provide a context
for interpreting review results. The first issue we faced was
how much information to extract. Our experience reading
and using very brief summaries of other systematic
reviews of complex interventions led us to opt for more,
rather than less, categories of information, because brevity
sometimes hindered understanding – for example, about
the content, format or delivery of complex interventions.
In addition, our experience of using reviews of interven-
tions for communication and participation in a policy
making context had confirmed our belief that there is con-
fusion in the language, purposes and outcomes of many
interventions for communication and participation. In
other words, there is a lack of an internationally shared
language for many of the main interventions in this field.
This meant that we opted for a comprehensive set of data
categories with the aim of avoiding potential confusion in
the use of the data.
Table 2: Assessment scheme for consistent reporting of review results
SUMMARY STATEMENT TRANSLATION CRITERIA
Sufficient evidence from trials Evidence sufficiently certain to support conclusions about the effect of the 
intervention(s) in relation to a specific outcome(s). This includes evidence of an effect in 
terms of (i) benefit or (ii) harm.
Criteria that need to be met:
￿ Statistically significant results are considered to represent sufficient evidence to 
support conclusions; or
￿ The numbers of trials/participants included in the analysis for a particular outcome 
are also considered. For example: meta-analysis yielding a statistically significant 
pooled result based on a large number of included trials/participants; or narrative data 
with statistically significant results, such as 12 studies of 14 showing a significant effect 
of an intervention on a particular outcome.
Some evidence from trials Less conclusive evidence to make a decision about the effects of a particular 
intervention(s) in relation to a specific outcome(s).
Criteria that need to be met:
￿ A narrative synthesis of results, with the result qualified according to the review 
findings, e.g., 'some evidence (5 studies of 9) reported a positive effect of ....' A rating 
of 'some evidence' is based on more equivocal results than those rated as 'sufficient 
evidence'. For example, while 12/14 statistically significant studies would be classed as 
'sufficient evidence', 5/9 statistically significant studies would be rated as 'some 
evidence'; or
￿ A rating of 'some evidence' may also be based on a statistically significant result 
obtained in a small number of trials; or a statistically significant result obtained from 
trials with a small number of participants.
Insufficient evidence from trials Not enough evidence to support conclusions about the effects of the intervention(s) on 
the basis of the included studies. This should be interpreted as 'no evidence of effect', 
rather than 'evidence of no effect'.
Criteria that need to be met:
￿ Statistically non-significant results; or
￿ Where the number of trials and/or participants is small, 'insufficient evidence' may 
reflect lack of power to be able to detect an effect of the intervention; or
￿ Where the number of trials and/or participants is large, 'insufficient evidence' may 
reflect underlying ineffectiveness of the intervention.
Insufficient evidence in relation to measurement Not enough evidence to support conclusions about the effects of the intervention due to 
a lack of reporting on the specified outcomes.
Criteria that need to be met:
￿ The review elected not to report on a particular outcome(s) despite being reported 
by included trials; or
￿ The review was not able to report on the outcome, as data for the outcome were 
not reported by included trials.BMC Medical Research Methodology 2009, 9:16 http://www.biomedcentral.com/1471-2288/9/16
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We developed a data extraction table based on these cate-
gories, piloted it iteratively and adapted it as required. The
main methodological issue we identified through this
process was quality assessment. We decided, in line with
the increasing international recognition of the importance
of quality assessment, that it was necessary to provide a
quality assessment of the systematic review and also of the
included studies, and so added this to later versions. In
addition, authors' conclusions were added as a composite
from the Discussion and Implications sections of the
Cochrane review in later versions as a consistency check
against the final stages of preparing the data integration
table.
To prepare tables, one investigator (RR) extracted data
from reviews. All data were checked for accuracy and com-
pleteness by a member of the team who had prepared the
originating Cochrane review.
Quality assessment: Quality of the review
The quality of the systematic reviews was assessed using a
measurement tool for Assessment of Multiple SysTemAtic
Reviews (AMSTAR) [20] which has been used by others to
assess systematic review quality [21]. This tool assesses the
quality of the systematic review process against eleven dis-
tinct criteria. A review meeting all eleven criteria is
regarded as a review of the highest quality.
Quality assessment: Quality of the review's included trials
We used the review authors' assessment of the quality of
included trials in each systematic review. The rationale
was that Cochrane reviews use rigorous methods, includ-
ing independent study quality assessment by at least two
review authors [2]. All reviews also undergo rigorous peer
and statistical refereeing prior to publication. We debated
using the GRADE approach [22] for rating the quality of
included trials, as it was developing alongside the current
methods, but decided against this for two reasons: no
reviews prepared for the Consumers and Communication
Review Group had yet used this approach, and it would
require significant additional work (that is, re-analysis of
included studies) to complete ourselves. In future this
option may become possible as more Cochrane review
authors adopt these new methods.
Output of Step 1: Key characteristics of reviews
Table 1 identifies the main characteristics of the review for
which data would be extracted and informs researchers
where they would usually find that data in a Cochrane
Systematic Review, or how it would be described. Data
items include: review aim; scope, which includes study
design, participants, interventions, comparison arms and
outcomes; number of studies; types of studies; number of
participants; method of analysis (that is, whether or not a
meta-analysis was performed); setting; recipient of the
intervention, provider of the intervention, and format;
quality of the review and of its included studies; and
authors' conclusions. The item 'recipient' classifies infor-
mation relevant to the direction of communication, is
adapted from the scope of the Consumers and Communi-
cation Review Group, and recognises that communication
is a dynamic social process and not unidirectional.
Step 2: Assessing the review results
Developing an evidence assessment scheme
A scheme to assess the results of reviews was developed to
allow consistent reporting of findings across reviews. We
examined a range of review-level syntheses produced by
different groups who were summarising systematic
reviews of complex interventions (including the Health
Development Agency, the Community Guide and groups
within or affiliated with the Cochrane Collaboration [17])
to determine the types of schemes in use and their charac-
teristics. We decided that the main features of the scheme
were that it had to be able to:
￿ represent accurately and consistently results that were
statistically pooled, or narratively reported, or combina-
tions of the two;
￿ differentiate clearly between results that were reasonably
certain; those where effects were less certain or uncertain;
and those where data were absent.
Table 3: Taxonomy of outcomes for communication and 
participation
Consumer oriented outcomes
Knowledge and understanding
Communication
Patient involvement in care process
Evaluation of care
Support
Skills acquisition
Health status and well being
Health behaviour
Treatment outcomes
Health care provider oriented outcomes
Knowledge and understanding
Consultation processes
Health service delivery oriented outcomes
Service delivery level
Related to research
Societal or governmental
Source: 'Outcomes of interest to the Cochrane Consumers and 
Communication Review Group', published at http://
www.latrobe.edu.au/cochrane/assets/downloads/Outcomes.pdfBMC Medical Research Methodology 2009, 9:16 http://www.biomedcentral.com/1471-2288/9/16
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Our initial scheme included three standardised evidence
statements to summarise review results in relation to a
specific outcome: sufficient evidence from trials (results
could be regarded as sufficiently certain to support con-
clusions about effects, either beneficial or harmful); insuf-
ficient evidence from trials (not enough evidence to
support conclusions about the results); and unclear (not
enough evidence to support a firm conclusion, or equivo-
cal results). We piloted this scheme on several reviews,
developing an evidence assessment for each and all pri-
mary and secondary outcomes identified by the authors of
the review. This led to modifications. 'Some evidence
from trials' was added to differentiate more clearly the
instances where results were more equivocal than would
be justified by the description 'sufficient evidence', such as
for a review with narrative synthesis where both positive
and negative results were reported for a given outcome. It
was also necessary to differentiate between a lack of evi-
dence due to statistically non-significant results, and cases
where there was lack of evidence due to insufficient
reporting. We therefore also added the term 'Insufficient
evidence in relation to measurement' to identify those
cases where there was a lack of reporting of results on rel-
evant outcomes, either at the included study level, or at
the level of the review.
Output of Step 2: Assessment scheme
The final scheme is provided in Table 2 and for a worked
example of Step 2, see Additional file 1. It provides four
assessment statements with criteria that need to be met for
each statement. Use of the scheme for subsequent project
work [7] has indicated that judgement is still required for
the distinction between 'sufficient' and 'some' evidence
from trials. Overall, Step 2 aims to ensure consistent
reporting of review-level findings for specific outcomes,
provide a broad assessment of the strength of evidence
derived from different methods of analysis, indicate a
degree of certainty with the result, and report gaps in the
evidence in a consistent way.
Step 3: Mapping the evidence
Structuring the reporting of outcomes using a taxonomy
The Consumers and Communication Review Group's
outcome taxonomy provides a framework with which to
organise outcomes relevant to communicating with and
involving consumers in health care [23]. It provides a
comprehensive pool of outcomes from which to identify
those relevant to specific interventions affecting people's
interactions with health care. It organises outcomes into
three major blocks: consumer-, health care provider- and
health service delivery-oriented outcomes (see Table 3).
Each block is broken down into broad outcome types rel-
evant to the effects of interventions for communication
and participation. These broad types have a thematic
coherence that is not present the more one breaks down
each category, and at the level of the review, many out-
comes are often highly specific, thus making synthesis at
a meta level very difficult.
The significance of this step is that we hypothesised that
policy makers may find it useful to have outcomes in an
overview mapped against a comprehensive but broad set
of health-related outcomes, in addition to data being
reported for the specific primary or secondary outcomes
from the originating review. For instance, a question at
overview level might be does X lead to improved knowl-
edge and understanding, changes in behaviour and
reduced use of health services. Reviews selected for inclu-
sion into an overview addressing this type of question
may not report all these outcomes or report them for a
narrowly defined and more specific outcome. In a related
methodological field (exploratory efforts to synthesise
quantitative and qualitative data in a systematic review
[24,25]) researchers had indicated the benefits of a struc-
tured report using thematically coherent categories to
organise diverse findings [26,27]. We would argue that
the taxonomy could provide a set of 'coherent categories'
and could be used to map the diverse findings of the
review as an input to meta-synthesis. Our hypothesis is yet
to be tested but we chose to map results in this way.
Output of Step 3: Mapping key outcomes
In practice, there are two small steps under the more gen-
eral 'mapping' step. The first was to analyse the outcomes
identified in each systematic review and to map them to
the relevant outcome taxonomy classifications. For exam-
ple, drawing from O'Connor's Cochrane review on deci-
sion aids [28], the outcomes knowledge, accuracy of risk
perception and realism of expectations would all map onto
the outcome taxonomy category of 'consumer knowledge
and understanding'.
Following this, the evidence rating scheme described
above was used to report the review's results against each
identified outcome type. The result of these steps is that
the evidence available for each consumer intervention-
related outcome can be gleaned by looking at one column
of the results table. Step 3 – in combination with data
from the other steps – is not the meta-synthesis but a step
towards it.
Step 4: Synthesis
Assessing the implications of the review
Based on the results of the outcome mapping and evi-
dence assessment steps, as well as the review authors' dis-
cussion and conclusions, the implications of each review
were assessed. The major conclusions represented in the
data integration tables are two-fold: the table serves to
report the conclusions of the original review authors, but
also reports the results of the data mapping and evidenceBMC Medical Research Methodology 2009, 9:16 http://www.biomedcentral.com/1471-2288/9/16
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assessment performed by the table author. In this way,
gaps in evidence or inconsistencies of reporting can be
readily identified.
Output of Step 4: Building block for meta-synthesis
In Additional file 1, the final Step 4 is worked through in
a systematic review of lay-led self-management. This step
does not require re-analysis of the review's component
data but is a building block to be used for meta-synthesis.
The synthesis statements remain consistent with the
review authors' work but also build in the results of the
data transformation performed in earlier steps.
This last step, and the tabular format in which the results
of each step are presented, facilitate further comparison
between reviews, that is, between data integration tables.
The resulting 'big picture' vantage point can be employed
to draft an overview via meta-synthesis that encompasses
large amounts of data.
Discussion
In this article we have outlined a four-step method for pre-
paring data integration tables to enable review-level syn-
thesis of the evidence on interventions for
communication and participation in health. The steps
allow for the selection and extraction of relevant data
from reviews, incorporation of quality assessment of the
review's included studies and an assessment of the system-
atic review itself. The strength of the review-level evidence
is assessed using standardised statements, and findings are
mapped in their original form to the outcome taxonomy
for communication and participation. Implications are
drawn in a consistent format based on the evidence assess-
ments and on the review authors' own conclusions.
Strengths, uses and limitations of this work
The tables aim to improve the relevance and consistency
of reporting on the effects of complex interventions; to
allow clear messages about the evidence to be drawn from
reviews, particularly around issues of certainty; and to
enable systematic identification of gaps in the evidence
base. The data integration tables are a building block with
which to undertake meta-synthesis and construct over-
view of reviews. A sharp rise in the number of available
systematic reviews has seen demand grow for methods to
summarise and synthesise review-level evidence [2,8-
13,29]. Overviews are one way of meeting these chal-
lenges. In addition, the discrete tables can serve as a valu-
able tool for accurate dissemination of data in individual
reviews to professionals as well as to members of the pub-
lic.
The data integration tables can be employed for various
uses, in addition to the development of overviews. We
have utilised and evaluated the format to disseminate new
review-level evidence via evidence bulletins: electronic
newsletters with wide distribution among professionals
and lay people that must maximise content in a limited
space [30,31]. Another avenue of data dissemination and
improving accessibility to evidence on communication
and participation is via publicly available internet-based
databases, an example of which is Rx for Change Database
[32].  Rx for Change is administered by the Canadian
Agency for Drugs and Technologies in Health and
includes evidence derived from systematic reviews that
deal with prescribing for and use of medicines by profes-
sionals and consumers. We utilised selected components
of data integration tables to generate review summaries
and to populate the consumer section of this database. As
part of this work, a Cochrane overview of systematic
reviews is in preparation, addressing the question: what
improves evidence-based prescribing for, and medicine
use by, consumers [7].
The development of the tables provided us with a rela-
tively succinct format, with well-demarcated sections,
allowing for location of key information as well as a more
easily digestible presentation. Some Cochrane systematic
reviews, particularly those with narrative presentation of
results, are substantial documents, and trade-offs had to
be made between detail and key messages. With this goal
in mind, the data integration table format maintains a
comprehensive representation of the original review arti-
cle, in that key descriptive data is maintained. Mapping
outcomes specific to the field of communication and par-
ticipation, and also performing an assessment of the level
of evidence available for each intervention, engenders an
end product that is more than the addition of characteris-
tics of the review plus results for review-level data. Rather,
the table represents an integration of summary and syn-
thesis. The transparency of process that makes it easily
replicable is also a valuable component.
The WHO Patient at the Centre project, which involved
gathering and synthesising a broad range of literature, also
benefited from the use of data integration tables in the
policy formulation process [33]. In conducting this
project, time and resource constraints made it impossible
to utilise fully the step where outcomes are mapped to the
Group's taxonomic categories (Step 3) and at that time,
there were insufficient published reviews coordinated by
the Group to prepare a stand alone overview addressing a
specific question. We have applied Step 3 only to reviews
coordinated by the Review Group. We believe that this
step would aid meta-synthesis but we remain unsure of its
value beyond our Group's reviews and would welcome
application by others.
One weakness of our method is that the summary evi-
dence statements still require interpretation, and may notBMC Medical Research Methodology 2009, 9:16 http://www.biomedcentral.com/1471-2288/9/16
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always be easy to apply, particularly for the process of evi-
dence assessment in the context of narrative reporting of
results in a review. However, we have used the approach
to summarise and assess 19 Cochrane reviews in the Rx for
Change Database of the Canadian Agency for Drugs and
Technologies in Health [32]. User testing of this database
is anticipated in the future and may help to clarify areas of
confusion or ambiguity.
Future research
The benefit of the comprehensive nature of the data inte-
gration tables is that it allows some extrapolation and
application of the results to local contexts – although this
is not yet an integrated component. Concurrent with the
methodological work described here has been the SUP-
PORT Project [34], with the development of review sum-
maries and an overview of interventions relevant to
primary care [35]. This will influence our ongoing work.
We may consider adding a step for 'evidence to practice/
policy' or translational issues. This could be derived from
the review, in conjunction with consideration of local fac-
tors, or could be further developed through focus group
research with key decision makers. Other concurrent
developments that may influence future research and test-
ing of our approach include the GRADE approach, as
mentioned, for rating the quality of included studies [36-
38], and the development of lay summaries of Cochrane
reviews using the Summary of Findings tables [2,39].
Implications for policy
We developed our approach in response to the particular
challenges we faced in relation to socially complex inter-
ventions: various methods of analysis in reviews, complex
interventions that are poorly described and understood,
and lack of awareness of the range of health outcomes in
the field of health communication and participation.
Mapping the evidence using the assessment scheme and
taxonomy clearly highlights relevant outcomes for inter-
ventions promoting communication and participation,
differentiates between outcomes where there is sufficient
evidence upon which to base a decision and less conclu-
sive bases. The latter would then presuppose a greater role
for preferences, value judgements or expert opinion sub-
ject to local circumstances [40]. Systematic gap analysis –
both for evidence and for outcomes – is also facilitated,
leading to easier identification of whether less rigorous
research or other study designs will be required to address
knowledge gaps. Given this context, we hope that they
will also enable evaluation of bodies of evidence as a the-
oretically-related whole, to assist decision makers by pro-
ducing a complete and concise representation of the
available evidence.
Deficiencies in the patient-centredness of care and poor
communication with consumers are persistent and perva-
sive problems in health care and a large range of interven-
tions now exist to promote active participation and
patient-centred care [10,41]. These interventions have the
potential to prevent and address the problems associated
with communication and participation, and the evidence
base from which to make decisions about the effectiveness
of these interventions continues to grow [42]. We share
with others the challenges of summarising reviews of
complex interventions and hope that the methods and
outputs described may offer a method for developing
coherent overviews for policy makers and other users.
Conclusion
The data integration tables represent a critical step in cre-
ating an overview: data extraction and quality assessment,
evidence assessment and mapping to produce consistent
messages in relation to a comprehensive set of relevant
outcomes. The method provides a transparent and flexible
tool for the field of consumer communication and partic-
ipation. Each data integration table includes relevant
information on the context and features of the review,
interventions, and results. This information is then evalu-
ated and processed in several steps, and the results of this
analysis are also included in the table. The final result is a
product that can be used on its own as a method of ana-
lysing data from a single review, used to develop deriva-
tive products, or, in the future, assembled in combination
with other data integration tables, with the purpose of
preparing overviews of multiple systematic reviews (meta-
synthesis) in the area of consumer communication and
participation.
The methods described here deal with the complexities of
the evidence base of interventions for improving social
interactions and attempt to take account of the challenges
of mixed analysis methods, complex and diverse interven-
tions, and multiple outcomes reported in different ways.
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